FDA.reportPublic FDA data

Ivy Dry Cream

Manufacturer
Ivy Dry, Inc.
Effective date
2019-12-26
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 23:02:21

Label at a glance#

ProductIvy Dry
Active ingredientBENZYL ALCOHOL, CAMPHOR (SYNTHETIC), MENTHOL
Label structure8 sections

Indications and uses

for the temporary relief of itching associated with insect bites and minor skin irritations.

Dosage and administration

Apply to affected area not more than 3 times daily. Children under 2 years of age: do not use, ask a doctor. Severe reactions to Urushiol (the chemical released by the plant, which causes the irritation) can look like chemical burns and have a thick leathery appearance. Additional applications may be necessary. Test product on small patch of skin before applying to the entire body.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Benzyl Alcohol 10%
Camphor 0.6%
Menthol 0.4%

Purpose

OTC - PURPOSE SECTION

External Analgesic

Uses

INDICATIONS & USAGE SECTION

for the temporary relief of itching associated with insect bites and minor skin irritations.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

  • face or genital areas
  • on a reas of blistered or broken skin
  • with a compress after application

When using this product

OTC - WHEN USING SECTION

do not get into eyes if contact occurs, flush eyes with water

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days.

If pregnant or breastfeeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Apply to affected area not more than 3 times daily.
  • Children under 2 years of age: do not use, ask a doctor.
  • Severe reactions to Urushiol (the chemical released by the plant, which causes the irritation) can look like chemical burns and have a thick leathery appearance. Additional applications may be necessary.
  • Test product on small patch of skin before applying to the entire body.

Other information

OTHER SAFETY INFORMATION

  • Store at room temperature.
  • You may report a serious adverse reaction to Report Reaction, LLC. PO Box 22, Plainsboro, NJ 08536-0222.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water, Structure XL, Cutina GMS, Phenoxol T, Cremaphor CO 40, Butylene Glycol, Zinc Acetate, Steareth-2,
Steareth-20, Steareth 100, Proaqua ISL, Pelemol IPM, Estol 1543, Glydant Plus, Dimethicone, VE Acetate, Allantoin.

DESCRIPTION SECTION

Made in the U.S.A. for:

IVY-DRY, INC.

299-B Fairfield Ave.

Fairfield, NJ 07070

©2012 Ivy-Dry, Inc.

Questions or Comments

www.ivydry.com


If you get Poison Ivy,

you know you’ll want

to use a product with

proven effectiveness

that you can trust.

Look no further than

Ivy Dry Products

known and trusted

for over 60 years.

Product Labeling

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TEMPORARY
RELIEF
OF PAIN
AND ITCHING
Associated with Minor Skin
Irritations and Insect Bites
External Analgesic


Ivy Dry CreamIvy Dry Cream

Ivy Dry CreamIvy Dry Cream

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1305913benzyl alcohol 10 % / camphor 0.6 % / menthol 0.4 % Topical CreamPSN3
1305916Ivy-Dry Cream 10 % / 0.6 % / 0.4 % Topical CreamPSN3
1305916benzyl alcohol 100 MG/ML / camphor 6 MG/ML / menthol 4 MG/ML Topical Cream [Ivy-Dry Cream]SBD3
1305913benzyl alcohol 100 MG/ML / camphor 6 MG/ML / menthol 4 MG/ML Topical CreamSCD3
1305913benzyl alcohol 10 % / camphor 0.6 % / menthol 0.4 % Topical CreamSY3
1305916Ivy-Dry Cream (benzyl alcohol 10 % / camphor 0.6 % / menthol 0.4 % ) Topical CreamSY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZYL ALCOHOL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
190f2a5b-bbc8-65c7-fcb0-97891307b917Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49546-201-282022-01-28C16284748780-1d6a99b39-eca2-a426-e053-dadaa90af4c2Ivy Dry Cream

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49546-201-28Ivy Dry28 g in 1 TUBECREAM283
49546-201-28Ivy Dry1 in 1 BOXCREAM13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49546-201IVY DRY (BENZYL ALCOHOL, CAMPHOR, MENTHOL) CREAM [IVY DRY, INC.]3Legacy NDC, 2 package rows20191227_5fe81556-5b5f-4765-9136-796e4974aed0.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BENZYL ALCOHOLACTIVE INGREDIENTLKG8494WBH2
CAMPHOR (SYNTHETIC)ACTIVE INGREDIENT5TJD82A1ET2
MENTHOLACTIVE INGREDIENTL7T10EIP3A2
BENZYL ALCOHOLACTIVE MOIETYLKG8494WBH2
CAMPHOR (SYNTHETIC)ACTIVE MOIETY5TJD82A1ET2
MENTHOLACTIVE MOIETYL7T10EIP3A2
ALLANTOININACTIVE INGREDIENT344S277G0Z2
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA2
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O2
DMDM HYDANTOININACTIVE INGREDIENTBYR0546TOW2
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE42
STEARETH-100INACTIVE INGREDIENT4OH5W9UM872
STEARETH-2INACTIVE INGREDIENTV56DFE46J52
STEARETH-20INACTIVE INGREDIENTL0Q8IK9E082
WATERINACTIVE INGREDIENT059QF0KO0R2
ZINC ACETATEINACTIVE INGREDIENTFM5526K07A2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49546-20149546-201-28

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
BUTYLENE GLYCOL3XUS85K0RAIACT
ZINC ACETATEFM5526K07AIACT
STEARETH-2V56DFE46J5IACT
STEARETH-20L0Q8IK9E08IACT
STEARETH-1004OH5W9UM87IACT
DMDM HYDANTOINBYR0546TOWIACT
DIMETHICONE92RU3N3Y1OIACT
ALLANTOIN344S277G0ZIACT
BENZYL ALCOHOLLKG8494WBHACTIB
CAMPHOR (SYNTHETIC)5TJD82A1ETACTIB
MENTHOLL7T10EIP3AACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 35 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALLANTOINALLANTOIN344S277G0ZGEL / TOPICAL8 mgExact identifier — unii candidate
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4SUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE, DELAYED RELEASE / ORAL15 mgExact identifier — unii candidate
21 equally ranked IID candidates
STEARETH-100STEARETH-1004OH5W9UM87OINTMENT / TOPICAL86 mgExact identifier — unii candidate
2 equally ranked IID candidates
STEARETH-100STEARETH-1004OH5W9UM87CREAM / TOPICAL50 mgExact identifier — unii candidate
2 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4AEROSOL, FOAM / TOPICAL3.27 %w/wExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4SUSPENSION / AURICULAR (OTIC)0.5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4SUPPOSITORY / RECTAL35 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE / ORAL13.75 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CREAM / VAGINAL140 mgExact identifier — unii candidate
21 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TRANSDERMAL8.12 mgExact identifier — unii candidate
2 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, CHEWABLE / ORAL1 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET / SUBLINGUAL1.23 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4EMULSION / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
ZINC ACETATEZINC ACETATEFM5526K07AINJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS2.3 mgExact identifier — unii candidate
3 equally ranked IID candidates
STEARETH-2STEARETH-2V56DFE46J5OINTMENT / TOPICAL714 mgExact identifier — unii candidate
4 equally ranked IID candidates
ZINC ACETATEZINC ACETATEFM5526K07AINJECTION / SUBCUTANEOUSNAExact identifier — unii candidate
3 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE, EXTENDED RELEASE / ORAL32.4 mgExact identifier — unii candidate
21 equally ranked IID candidates
STEARETH-2STEARETH-2V56DFE46J5CREAM / TOPICAL643 mgExact identifier — unii candidate
4 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4LOTION / TOPICAL177 mgExact identifier — unii candidate
21 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, DELAYED RELEASE / ORAL6 mgExact identifier — unii candidate
21 equally ranked IID candidates
STEARETH-20STEARETH-20L0Q8IK9E08CREAM / TOPICAL4.15 %w/wExact identifier — unii candidate
STEARETH-2STEARETH-2V56DFE46J5LOTION / TOPICAL0.4 %w/wExact identifier — unii candidate
4 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4OINTMENT / TOPICAL5 %w/wExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4AEROSOL, FOAM / VAGINAL3 %w/wExact identifier — unii candidate
21 equally ranked IID candidates
STEARETH-2STEARETH-2V56DFE46J5AEROSOL, FOAM / TOPICAL1.09 %w/wExact identifier — unii candidate
4 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4GRANULE, FOR SUSPENSION / ORAL4 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CREAM / TOPICAL836 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, EXTENDED RELEASE / ORAL529 mgExact identifier — unii candidate
21 equally ranked IID candidates
ZINC ACETATEZINC ACETATEFM5526K07ASWAB / TOPICALNAExact identifier — unii candidate
3 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL23 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4LIQUID / TOPICAL1 %w/wExact identifier — unii candidate
21 equally ranked IID candidates
DMDM HYDANTOINDMDM HYDANTOINBYR0546TOWLOTION / TOPICAL3 mgExact identifier — unii candidate
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET / ORAL33.34 mgExact identifier — unii candidate
21 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9aa072fa-2c91-d2ea-e053-2995a90a84555fe81556-5b5f-4765-9136-796e4974aed02019-12-26WarningsExact identifier
spl id: 9aa072fa-2c91-d2ea-e053-2995a90a8455
spl set id: 5fe81556-5b5f-4765-9136-796e4974aed0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.